Actinomycetota From Macroalgae as Rich Source for Natural Products Discovery Revealed Through Culture‐Dependent and ‐Independent Approaches
Open Access
- 18 December 2024
- journal article
- research article
- Published by Wiley in Microbial Biotechnology
- Vol. 17 (12) , e70058
Abstract
Actinomycetota are unrivalled producers of bioactive natural products, with strains living in association with macroalgae representing a prolific—yet largely unexplored—source of specialised chemicals. In this work, we have investigated the bioactive potential of Actinomycetota from macroalgae through culture‐dependent and ‐independent approaches. A bioprospecting pipeline was applied to a collection of 380 actinobacterial strains, recovered from two macroalgae species collected in the Portuguese northern shore— Codium tomentosum and Chondrus crispus— in order to explore their ability to produce antibacterial, antifungal, anticancer and lipid‐reducing compounds. Around 43% of the crude extracts showed activity in at least one of the screenings performed: 111 presented antimicrobial activity at 1 mg/mL, 83 significantly decreased cancer cells viability at 15 μg/mL and 5 reduced lipid content in zebrafish > 60% at 15 ug/mL. Dereplication of active extracts unveiled the presence of compounds that could explain most of the recorded results, but also unknown molecules in the metabolome of several strains, highlighting the opportunity for discovery. The bioactive potential of the actinobacterial community from the same macroalgae specimens, which served as the source for the aforementioned Actinomycetota collection, was also explored through metagenomics analysis, allowing to obtain a broader picture of its functional diversity and novelty. A total of 133 biosynthetic gene clusters recovered from metagenomic contigs and metagenome assembled genomes (MAGs). These were grouped into 91 gene cluster families, 83 of which shared less than 30% of similarity to database entries. Our findings provided by culture‐dependent and ‐independent approaches underscore the potential held by actinomycetes from macroalgae as reservoirs for novel bioactive natural products.Keywords
Funding Information
- European Regional Development Fund (UIDB/04423/2020)
- Fundação para a Ciência e a Tecnologia (CEECIND/02968/2017, FRH/BD/145646/2019)
This publication has 78 references indexed in Scilit:
- Detection of gene pathways with predictive power for breast cancer prognosisBMC Bioinformatics, 2010
- Isolation and Characterization of Tirandamycins from a Marine-Derived Streptomyces sp.Journal of Natural Products, 2009
- Antimicrobial activity observed among cultured marine epiphytic bacteria reflects their potential as a source of new drugsFEMS Microbiology Ecology, 2009
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Marine actinobacteria: new opportunities for natural product search and discoveryTrends in Microbiology, 2007
- Abyssomicin C—A Polycyclic Antibiotic from a Marine Verrucosispora Strain as an Inhibitor of the p‐Aminobenzoic Acid/Tetrahydrofolate Biosynthesis PathwayAngewandte Chemie International Edition, 2004
- MUSCLE: multiple sequence alignment with high accuracy and high throughputNucleic Acids Research, 2004
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Mode of action of orlistat.1997
- Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity.The Journal of Antibiotics, 1987